- Open Access
Neonatal sepsis in Sana’a city, Yemen: a predominance of Burkholderia cepacia
BMC Infectious Diseases volume 21, Article number: 1108 (2021)
Neonatal sepsis is a global concern with increasing morbidity and mortality. The burden of neonatal sepsis is highest in developing countries, especially in those lacking proper surveillance systems. The causative pathogens and their drug-resistance levels vary between countries with emergence of multidrug resistance organisms. Thus, accurate records on the recent trends of organisms causing neonatal sepsis will provide vital information for appropriate intervention. We aimed to investigate neonatal sepsis, identify its associated factors and causative pathogens and to assess the antibiotic susceptibility patterns in Sana’a city, Yemen.
A cross-sectional study was conducted on neonates admitted to intensive care units of six hospitals in Sana’a city, Yemen, in the period from January 15, to March 30, 2020. Natal and prenatal medical data were collected using well-structured questionnaire. Neonates were subjected to sepsis work-up including blood culture, complete blood count and C-reactive protein. Organisms were identified by Gram staining and analyzed by the VITEK II system for bacterial bio-typing and antibiotic susceptibility testing.
Of the 199-neonates with suspected neonatal sepsis, 154 (77.38%) had culture-proven sepsis. Early-onset neonatal sepsis (EOS) was higher (50.25%; 100/199) than late-onset neonatal sepsis (LOS) (27.13%; 54/199). Multivariable analysis identified vaginal delivery as an independent risk factor for neonatal sepsis p = 0.005. Majority of isolated bacteria (74.39%) were gram-negative with Burkholderia cepacia (39%) and Klebsiella oxytoca (13%) being the most common pathogens of EOS and LOS. The most common gram-positive pathogens were Staphylococcus haemolyticus (9.1%) and Staphylococcus epidermidis (7.1%). B. cepacia showed multidrug resistance except for cefepime. All Klebsiella species isolates (100%) and most Pantoea species (93%) were ESBL and carbapenemase positive. All Escherichia coli and Acinetobacter baumannii isolates were ESBL positive. A significant number of gram-positive bacteria showed resistance to vancomycin.
The study findings show a high proportion of neonatal sepsis among neonates admitted to hospitals in Sana’a city with antibiotic-resistant B. cepacia being the single most common pathogen causing EOS and LOS. Findings also emphasize the emerging threat of multidrug-resistant bacteria in neonatal units and will help develop evidence-based management of neonatal sepsis in Yemen.
Neonatal sepsis is a leading cause of neonatal morbidity and mortality worldwide. The global burden of neonatal sepsis and other neonatal infections was estimated at 22 million disability-adjusted life-years (95% UI: 18.9–28.0) . In developing countries, neonatal sepsis is responsible for more than 50% of neonatal deaths. It includes EOS, which occurs within 72 h after birth and LOS . The two types of infections have different clinical manifestations, epidemiology, and pathogens patterns [3,4,5,6].
Pathogens causing neonatal sepsis are either acquired from the maternal flora or postnatally from the hospital or community . Bacteria are the most common pathogens, and they vary in the distribution between countries, regions and according to the disease onset EOS versus LOS . The commonly involved bacteria in developing countries include Klebsiella species, Staphylococcus aureus, E. coli, and Group B Streptococcus [8, 9]. Recently, B. cepacia, a bacterial pathogen that has intrinsic drug resistance and ability to live inside drug products [10, 11], has emerged as a significant pathogen causing neonatal sepsis [12,13,14,15,16].
Yemen is suffering of an ongoing war that started in 2015. The war has destroyed the health system, rendering health facilities either not functioning or partially functioning . There is a paucity of information about neonatal sepsis including its types, causative pathogens patterns and antibiotic susceptibility. Therefore, this study aimed to investigate neonatal sepsis, identify its associated factors and causative pathogens, and to assess the antibiotic susceptibility patterns in Sana’a city, Yemen. Findings from this study will fill gaps of knowledge about neonatal sepsis in Yemen, helping public health authorities to develop an effective control strategy to combat the disease, and guide Yemeni physicians to implement an evidence-based approach for the clinical management of neonatal sepsis.
All methods were carried out in accordance with the relevant guidelines and regulations.
Study design and subjects
This was a cross-sectional study conducted on neonates admitted to neonatal units in six major hospitals in Sana’a city; Al-Kuwait, C-Plas, Al-Gumhory, Al-Sabeen, AL-Thawra, and Family hospitals, in the period from January 15 to March 30, 2020. Neonates who were admitted for at least 72 h with suspected sepsis during the study period were included. Neonates with congenital anomalies and hemolytic jaundice were excluded from the study.
Diagnosis of neonatal sepsis
Neonatal sepsis was suspected based on the presence of clinical signs or risk factors according to the international recommendations  and confirmed as neonatal sepsis if blood culture was positive [18, 19]. Neonatal sepsis was then classified into EOS and LOS .
Bio and socio-demographic data were collected using a standard questionnaire by face-to-face interviews with the neonate’s mothers. The health condition of the mothers and clinical manifestations of the neonates were collected by physicians using standard tools. Written informed consent was obtained from guardians of all neonates after explaining the study objectives. All procedures described in this study were approved by the Research and Ethics Committee of the Faculty of Medicine and Health Sciences, University of Science and Technology, Sana’a (Approval No. EAU/UST122).
Laboratory investigations were performed according to standard microbiological techniques . Under aseptic conditions, trained nurses collected blood samples that were used for laboratory investigations of complete blood counts, C-reactive proteins and blood culture. For culture, at least 1 ml of blood was inoculated into BacT/Alert PF plus culture bottle (BIOMERIEUX, France, LOT 4053532) and incubated until the BacT/Alert instrument (BACTEC 9050, Becton Dickinson) signals it either as positive or negative. All positive samples were sub-cultured on choclate agar, blood agar, and MacConkey agar and incubated at 37 °C for 24–48 h. Gram-staining was conducted to differentiate between gram-positive and gram-negative bacteria. A sufficient number of colonies of pure culture was used to suspend the microorganism in 3.0 ml of sterile saline test tube. Pure bacterial suspension was added to bacterial specific identification and sensitivity testing kit device and analyzed by the VITEK II system for bacterial bio-typing and antibiotic susceptibility patterns as instructed in the product information manuals (BIOMERIEUX). VITEK® GN ID identification card (lot 2410933203) was used to characterize gram-negative bacteria and VITEK® GP ID identification card (lot 2420938203) was used to characterize gram-positive bacteria. Different cards were used to perform antibiotic susceptibility tests; AST-GN 87 (lot; 6770912203), AST-GN 72(lot; 5921083103) and AST GN75 (lot; 5951129403) for gram-negative bacteria and AST-GP67 (lot; 1321137103) for gram-positive bacteria. All procedures were conducted for routine diagnostic and therapeutic reasons.
Data were analyzed using IBM SPSS Statistics for Mac, version 23.0 (IBM Corp., Armonk, NY, USA). Categorical variables were presented in frequencies. The association between independent and dependent variables was tested using Pearson’s Chi-squared with reporting odds ratio (OR) and 95% confidence interval (CI). Fisher’s exact test was used when applicable. Multivariable analysis using the binary logistic regression model was conducted, including all variables, and the adjusted OR with its corresponding 95%CI was reported. A p-value of < 0.05 was considered significant.
The study protocol was approved by the Research and Ethics Committee of the Faculty of Medicine and Health Sciences, University of Science and Technology, Sana’a, Yemen (Approval No. EAU/UST122).
Characteristics of the patients
A total of 199 neonates admitted to referral hospitals in Sana’a city, Yemen, were enrolled in this study. Nearly half of neonates (84, 42.2%) were preterm, majority of them (70, 83.3%) were moderates to late preterm. More than half of neonates (109, 54.8%) were low birth weight. A total of 113 neonates (56.8%) were born by vaginal delivery. The age of 133 neonates (66.8%) was less than 72 h on admission. Tachypnea, lethargy and poor feeding were the most common clinical manifestations observed among neonates (Table 1).
Culture-confirmed neonatal sepsis and its associated factors
Majority of neonates 77.38% (154/199) had positive blood culture. Of them, 50.25% (100/199) had EOS. Neonates born by vaginal delivery were at three-times higher risk of neonatal sepsis (OR = 3.08, 95% CI 1.54, 6.16; p = 0.002) than those whose deliveries were through Cesarean section. Although most neonates born at home acquired neonatal sepsis (OR = 2.8; 95% CI 0.81, 9.87; p = 0.09), the significance of association was in the borderline (Table 2). Multivariable analysis using binary logistic regression model identified vaginal delivery as an independent risk factor for neonatal sepsis (adjusted OR = 3.0; 95% CI 1.40, 6.33, p = 0.005).
Clinical manifestations and hematological factors associated with culture-confirmed sepsis
Culture confirmed neonatal sepsis was significantly associated with hyperthermia (p = 0.045) and convulsion (p = 0.01). Poor feeding, jaundice, irritability, and lethargy were not significantly associated with neonatal sepsis. Elevated C-reactive protein was significantly associated with neonatal sepsis (p = 0.001). One-third (32%) of neonates with proven sepsis had normal white cell counts and two-thirds (59%) had normal platelets counts (Table 3).
Pathogens causing neonatal sepsis
Table 4 represents the distribution of pathogens causing neonatal sepsis. Out of the 154 neonates with culture-confirmed sepsis, 152 were infected by bacteria, while two were infected by Candida albicans. Of the 152 neonates with proven bacterial culture, nine had mixed bacterial growth. We isolated 161 bacterial pathogens, 119 (74%) were gram-negative while 42 (26%) were gram-positive. B. cepacia (37%) was the most common organism causing neonatal sepsis with higher prevalence among EOS (38%) than LOS (35%), followed by K. oxytoca (11.6%), which was higher among LOS (14.8%) than EOS (10.0%). Pantoea agglomerans caused neonatal sepsis in nine neonates (5.8%). The main gram-positive pathogens were S. haemolyticus (9.1%), S. epidermidis (7.1%) and Staphylococcus hominis (5.1%). Coagulase-negative Staphylococci (CONS) was the most common gram-positive organisms. S. haemolyticus emerged as the most frequently CONS.
Most isolated pathogens showed antimicrobial resistance (AMR) to the commonly used antibiotics (ampicillin, gentamicin, amikacin), cephalosporins and carbapenems (Tables 5 and 6). B. cepacia, the most common pathogen caused neonatal sepsis in this study, was highly resistant to ampicillin/sulbactam, gentamicin, tobramycin, tetracycline, amoxicillin/clavulanic acid, cefalotin, cefazolin, cefuroxime, cefoxitin, cefpodoxime, imipenem, and amikacin. However, it was 100% susceptible to cefepime. K. oxytoca was susceptible to gentamicin, ciprofloxacin, levofloxacin, tetracycline, nitrofurantoin, and trimethoprim/sulfamethoxazole. Klebsiella species (100%) and Pantoea species (93%) were carbapenemase positive and ESBL positive. All isolates of E. coli and A. baumannii were ESBL positive (Table 5). A significant number of gram-positive isolates were resistant to vancomycin. Most gram-positive bacteria were cefoxitin screening positive and sensitive to moxifloxacin, linezolid and rifampicin. S. haemolyticus isolates were resistant to ampicillin and gentamicin (Table 6). Staphylococcus species showed resistance to fluoroquinolones (ciprofloxacin).
In this multicentric cross-sectional study we report a high proportion of culture-confirmed neonatal sepsis, accounting for two-thirds (77.38%) of admitted neonates in the referral hospitals in Sana’a city in Yemen. EOS was more common than LOS and B. cepacia emerged as the predominant causative organism of both EOS and LOS. Majority of the isolated pathogens were resistant to commonly used antibiotics.
Culture confirmed sepsis was high in our study. However, the proportion of culture-confirmed neonatal sepsis varied between studies from developing countries; 62.8% in Pakistan , 57% in Yemen , 45.9% in Egypt , 44.7% in Ethiopia , 24% in Tanzania  and 12.6% in Nepal . The differences in the proportion of neonatal sepsis between countries may be due to several factors including sample size and the different used techniques.
In this study, EOS was about two times higher than LOS, which is consistent with other reports from developing countries [22, 23, 26, 27]. However, it is inconsistent with reports from developed countries where LOS is the predominant type of neonatal sepsis [28, 29]. The predominance of EOS in developing countries can be attributed to low quality health services and poor hygiene. This is mainly due to illiteracy, ignorance, cultural beliefs, and prejudices . Infection may be of the maternal genital tract or from delivery rooms or neonatal units [19, 30].
Similar to previous studies neonates born by vaginal delivery were at a higher risk of neonatal sepsis compared with those delivered through Cesarean section [23, 27]. Further, culture confirmed sepsis was high (89.9%) among home delivered neonates. Conversely, majority (75.3%) of the hospital delivered neonates had culture confirmed sepsis. These results emphasize on both the vertical and nosocomial transmission of the causative pathogens.
In this study, gram-negative bacteria were the most common cause of EOS and LOS, which is consistent with previous reports from developing countries [8, 9, 22, 31]. Unexpectedly, B. cepacia emerged as the most common cause of neonatal sepsis. It was found in all neonatal units. Moreover, it was resistant to aminoglycosides, fluoroquinolones and imipenem. B. cepacia has been reported to cause multiple hospital outbreaks and significant neonatal septicemia in different countries [12,13,14,15,16]. Also, it has been isolated from intravenous solutions, mouthwash, disinfectant and medical devices [31,32,33]. This organism is often overlooked and reported as Pseudomonas species [33, 34]. To our knowledge, this is the first report of B. cepacia from Yemen.
Staphylococcus haemolyticus was the most frequently isolated CONS in this study. Most isolated S. haemolyticus showed variable degrees of antibiotic resistance, which is the nature of S. haemolyticus to acquire antibiotic resistance due to unusual genome plasticity . So, this organism has a great ability to survive in the hospital environment, especially on medical devices.
Our results of antimicrobial resistance profile are consistent with other findings. Though some of the previous reports were based on cultures from different kinds of medical specimens and performed by conventional methods [8, 24, 28, 36,37,38,39]. Most of the isolated gram-negative and gram-positive pathogens were resistant to commonly used antibiotics, penicillins, cephalosporins and carbapenems. Increased antimicrobial resistance in developing countries is due to multiple factors including poverty, self-medication, unregulated supply and drug smuggling, misguided practice and inappropriate prescriptions [40, 41]. Such factors may provoke changes in causative agents together with their change in antibiotic susceptibility patterns [40, 41]. Markedly, majority of neonates in this study received antibiotics before sampling. The presence of ESBL and carbapenemase-positive gram-negative bacteria is an alarming sign both locally and globally and increases the burden of neonatal sepsis in Yemen.
Proven sepsis was associated with elevated CRP. Elevated CRP indicates activation of the immune system and is commonly used as an indicator of bacterial sepsis [18, 19]. The variation in the total white cell counts and platelet counts is considered a hematological response to inflammation, but there was no association between the culture-positive and culture-negative groups regarding white cell or platelets counts. This may be explained by considering evolving neonatal immune system [18, 19].
Culture-positive neonatal sepsis is high in Sana’a city with EOS representing two-thirds of the cases. B. cepacia followed by K. oxytoca and S. haemolyticus were the most common causes of both EOS and LOS. Majority of the isolated bacterial pathogens showed a high level of resistance to commonly used antibiotics. Vaginal delivery held high risk for developing neonatal sepsis. The study results emphasize the emergence of multidrug-resistant bacteria in the NICUs and might serve as a baseline for proper medical treatment of neonatal sepsis in Sana’a city.
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–922.
Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21–47.
Kristóf K, Kocsis E, Nagy K. Clinical microbiology of early-onset and late-onset neonatal sepsis, particularly among preterm babies. Acta Microbiol Immunol Hung. 2009;56(1):21–51.
Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):F257-263.
Afonso EDP, Blot S. Effect of gestational age on the epidemiology of late-onset sepsis in neonatal intensive care units—a review. Expert Rev Anti Infect Ther. 2017;15(10):917–24.
You T, Zhang H, Guo L, Ling K-R, Hu X-Y, Li L-Q. Differences in clinical characteristics of early- and late-onset neonatal sepsis caused by Klebsiella pneumoniae. Int J Immunopathol Pharmacol. 2020;34:2058738420950586.
Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770–80.
Downie L, Armiento R, Subhi R, Kelly J, Clifford V, Duke T. Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO’s currently recommended antibiotics–systematic review and meta-analysis. Arch Dis Child. 2013;98(2):146–54.
Sgro M, Campbell DM, Mellor KL, Hollamby K, Bodani J, Shah PS. Early-onset neonatal sepsis: organism patterns between 2009 and 2014. Paediatr Child Health. 2020;25(7):425–31.
Singhal T, Shah S, Naik R. Outbreak of Burkholderia cepacia complex bacteremia in a chemotherapy day care unit due to intrinsic contamination of an antiemetic drug. Indian J Med Microbiol. 2015;33(1):117–9.
Glowicz J, Crist M, Gould C, Moulton-Meissner H, Noble-Wang J, de Man TJB, et al. A multistate investigation of health care-associated Burkholderia cepacia complex infections related to liquid docusate sodium contamination, January–October 2016. Am J Infect Control. 2018;46(6):649–55. https://doi.org/10.1016/j.ajic.2017.11.018.
Mali S, Dash L, Gautam V, Shastri J, Kumar S. An outbreak of Burkholderia cepacia complex in the paediatric unit of a tertiary care hospital. Indian J Med Microbiol. 2017;35(2):216–20.
Antony B, Cherian EV, Boloor R, Shenoy KV. A sporadic outbreak of Burkholderia cepacia complex bacteremia in pediatric intensive care unit of a tertiary care hospital in coastal Karnataka, South India. Indian J Pathol Microbiol. 2016;59(2):197–9.
Sundaram V, Kumar P, Dutta S, Mukhopadhyay K, Ray P, Gautam V, et al. Blood culture confirmed bacterial sepsis in neonates in a North Indian tertiary care center: changes over the last decade. Jpn J Infect Dis. 2009;62(1):46–50.
Bharara T, Chakravarti A, Sharma M, Agarwal P. Investigation of Burkholderia cepacia complex bacteremia outbreak in a neonatal intensive care unit: a case series. J Med Case Rep. 2020;14(1):76. https://doi.org/10.1186/s13256-020-02415-8.
Yonas E, Damay V, Pranata R, Nusarintowati N. Infective endocarditis due to Burkholderia cepacia in a neonate: a case report. J Med Case Rep. 2018;12(1):120. https://doi.org/10.1186/s13256-018-1633.
Qirbi N, Ismail SA. Health system functionality in a low-income country in the midst of conflict: the case of Yemen. Health Policy Plan. 2017;32(6):911–22. https://doi.org/10.1093/heapol/czx031.
Kliegman RM, Stanton BF, St. Geme JW, Nina F. Nelson text book of pediatrics. In: Lielgman RM, Behrman RE, Jenson H, Staton B, editors. Sepsis septic shock and systemic inflammatory response syndrome. 20th ed. Philadelphia: Elseiver; 2016. p. 1094.
Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61(1):1–13. https://doi.org/10.1093/tropej/fmu079.
Isenbergh HD. Clinical microbiology procedures handbook. 2nd ed. Washington: ASM Press; 2004.
Rahman S, Hameed A, Roghani MT, Ullah Z. Multidrug resistant neonatal sepsis in Peshawar, Pakistan. Arch Dis Child Fetal Neonatal Ed. 2002;87(1):F52-54.
Al-Shamahy HA, Sabrah AA, Al-Robasi AB, Naser SM. Types of bacteria associated with neonatal sepsis in Al-Thawra University Hospital, Sana’a, Yemen, and their antimicrobial profile. Sultan Qaboos Univ Med J. 2012;12(1):48–54.
Shehab El-Din EMR, El-Sokkary MMA, Bassiouny MR, Hassan R. Epidemiology of neonatal sepsis and implicated pathogens: a study from Egypt. Biomed Res Int. 2015;2015:509484.
Shitaye D, Asrat D, Woldeamanuel Y, Worku B. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia. Ethiop Med J. 2010;48(1):11–21.
Mhada TV, Fredrick F, Matee MI, Massawe A. Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome. BMC Public Health. 2012;12:904.
Ansari S, Nepal HP, Gautam R, Shrestha S, Neopane P, Chapagain ML. Neonatal septicemia in Nepal: early-onset versus late-onset. Int J Pediatr. 2015;2015:379806. https://doi.org/10.1155/2015/379806.
Kamath S, Mallaya S, Shenoy S. Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram. Indian J Pediatr. 2010;77(1):37–9.
Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 2011;96(1):F9-14.
Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817–26.
Zaidi AKM, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009;28(1 Suppl):S10-18.
Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. J Infect Dev Ctries. 2009;3(4):273–7.
Doit C, Loukil C, Simon A-M, Ferroni A, Fontan J-E, Bonacorsi S, et al. Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers. J Clin Microbiol. 2004;42(5):2227–30. https://doi.org/10.1128/JCM.42.5.2227-2230.2004.
Sousa SA, Ramos CG, Leitão JH. Burkholderia cepacia complex: emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int J Microbiol. 2011. https://doi.org/10.1155/2011/607575.
Devanga Ragupathi NK, Veeraraghavan B. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update. Ann Clin Microbiol Antimicrob. 2019;18(1):7. https://doi.org/10.1186/s12941-019-0306-0.
Czekaj T, Ciszewski M, Szewczyk EM. Staphylococcus haemolyticus—an emerging threat in the twilight of the antibiotics age. Microbiology (Reading). 2015;161(11):2061–8.
Badulla WFS, Alshakka M, Mohamed Ibrahim MI. Antimicrobial resistance profiles for different isolates in Aden, Yemen: a cross-sectional study in a resource-poor setting. Biomed Res Int. 2020;2020:1810290. https://doi.org/10.1155/2020/1810290.
Dagnew M, Yismaw G, Gizachew M, Gadisa A, Abebe T, Tadesse T, et al. Bacterial profile and antimicrobial susceptibility pattern in septicemia suspected patients attending Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2013;6:283.
Awad HA, Mohamed MH, Badran NF, Mohsen M, Abd-Elrhman A-SA. Multidrug-resistant organisms in neonatal sepsis in two tertiary neonatal ICUs, Egypt. J Egypt Public Health Assoc. 2016;91(1):31–8.
Viswanathan R, Singh AK, Basu S, Chatterjee S, Sardar S, Isaacs D. Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India. Arch Dis Child Fetal Neonatal Ed. 2012;97(3):F182-187.
Chokshi A, Sifri Z, Cennimo D, Horng H. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11(1):36–42. https://doi.org/10.4103/jgid.jgid_110_18.
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47. https://doi.org/10.1186/s13756-017-0208-x.
The authors express their deepest gratitude to the administrative and staff members of the Al-Kuwait, C-Plas, Al-Gumhory, Al-Sabeen, Family, and AL-Thawra hospitals, especially those who work in the NICU for their participation and support for the success of this study. Special thanks are also due to Dr.Ahlam Esmail of the AL-Thawra hospital and Dr. Hana Sabbar of Al-Gumhory Hospital, Sana’a, Yemen, for their help in collecting specimens.
This study received financial support from the WHO/EMRO Grant Scheme for Research in Priority Areas of Public Health (RPPH-18-8).
Ethics approval and consent to participate
The study protocol was approved by the Research and Ethics Committee of the Faculty of Medicine and Health Sciences, University of Science and Technology, Sana’a, Yemen (Approval No. EAU/UST122). Written informed consent was obtained from guardian of all children after explaining the study objectives.
Consent for publication
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Salah, A., Al-Subol, I., Hudna, A. et al. Neonatal sepsis in Sana’a city, Yemen: a predominance of Burkholderia cepacia. BMC Infect Dis 21, 1108 (2021). https://doi.org/10.1186/s12879-021-06808-y
- Antibiotic resistance
- VITEK II
- Blood culture
- Burkholderia cepacia